On September 24, 2018 Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on the development of curative therapeutics using CRISPR/Cas9 technology, reported that it will participate in the following upcoming healthcare conferences in October (Press release, Intellia Therapeutics, SEP 24, 2018, View Source [SID1234529769]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Monday, October 1, 2018
Cantor Fitzgerald Healthcare Conference
Location: New York, NY
Time: 4:40pm ET

Tuesday, October 2, 2018
Leerink Partners Roundtable Series: Rare Disease & Oncology
Location: New York, NY
Time: 10:30am ET

Tuesday, October 9, 2018
Chardan Genetic Medicines Conference
Location: New York, NY
Time: 1:30pm ET

A live webcast of Intellia’s presentations will be accessible through the Events and Presentations page of the Investor Relations section of the company’s website at www.intelliatx.com. To access the webcasts, please log on to the Intellia website approximately 15 minutes prior to the start time to ensure adequate time for any software downloads that may be required. A replay of the webcasts will be available on Intellia’s website for approximately 14 days following each conference.